IL1B and major depressive disorder: In MDD adults, reports on IL-1β describe significantly lower levels of IL-1β in MDD patients without treatment, regarding the control group [34], yet these values are increased after 20 weeks of SSRI treatment, being significantly higher than those of the controls at week 52 [26].